IDH1 Gene

What the IDH1 Gene Means

The IDH1 gene is a part of your body's instructions for making a protein that helps cells break down fats to produce energy. This protein also helps protect cells from harmful molecules that can cause damage. The gene is found in many cells and plays a role in normal cell function.

Why IDH1 Gene Changes Matter in Cancer

Sometimes, the IDH1 gene can have mutations, which are changes in its usual structure. These mutations have been found in several types of cancer, including acute myelogenous leukemia (AML), myelodysplastic syndromes, and certain brain cancers. When the IDH1 gene is mutated, it can cause cells to behave abnormally, growing and spreading in ways that lead to cancer.

Because these mutations affect how cells work, they can be important in understanding the cancer’s behavior and deciding on treatment options. Some newer cancer drugs specifically target the abnormal protein made by the mutated IDH1 gene to help control the cancer.

Where You Might Encounter the Term IDH1 Gene

You may see the term IDH1 gene in medical reports, test results, treatment plans, or discussions about your cancer. It might also appear on clinical trial pages or drug information sheets, especially if your cancer has been tested for this mutation. The gene is sometimes called isocitrate dehydrogenase-1 gene, so both names refer to the same thing.

What IDH1 Gene Mutations Do Not Automatically Mean

Finding a mutation in the IDH1 gene does not by itself provide a full diagnosis or predict exactly how the cancer will behave. It is one piece of information among many that doctors use to understand the cancer and plan treatment. Not all cancers have this mutation, and not all patients with the mutation will have the same experience or response to treatment.

How Doctors Use IDH1 Gene Information

Doctors may test for IDH1 gene mutations to help guide treatment decisions. If a mutation is found, targeted therapies like ivosidenib (Tibsovo) or olutasidenib (Rezlidhia) may be options. These drugs work by blocking the abnormal protein made by the mutated gene, which can help slow or stop cancer growth. Testing for IDH1 mutations can also be part of clinical trials exploring new treatments.

Common Questions to Ask Your Care Team

If the IDH1 gene mutation comes up in your care, you might ask: What does this mutation mean for my cancer? Are there treatments that target this mutation? How will this affect my treatment plan or prognosis? Should I consider genetic testing or clinical trials? Understanding how this gene relates to your specific situation can help you feel more informed and involved in your care.

Understanding the Term in Context

Because the IDH1 gene can be listed under different names and appears in various parts of medical records, it’s important to ask your care team to explain what it means in your specific case. This helps avoid confusion and ensures you get clear information about your diagnosis and treatment options.

Important Safety and Next Steps

This information is educational and does not replace medical advice. The presence of an IDH1 gene mutation and related treatments should be discussed with your healthcare providers, who can explain what is safe and appropriate for you. If you see this term in your medical records or hear it during visits, the best next step is to ask your care team to explain what it means for your care and what options you have.